New reports from the ACC and AHA explore the use of noninvasive CCTA offerings that use advanced AI to evaluate patients with suspected CAD. These technologies have gained significant momentum in recent years, and experts agree that they represent a game-changing advancement in the world of cardiovascular imaging.

The case dates to July 2019, when breast specialist Claire Hanley, MD, first filed suit against New York City Health and Hospitals Corp. 

Rads and other physicians have roundly criticized the change, labeling the policy as “deeply flawed and operationally unworkable.”